Axogen, Inc. — Investor Relations & Filings
Filings indexed
1,140
across all filing types
Latest filing
2026-04-29
Annual Report
Country
US
United States of America
Listing
US
AXGN
Axogen, Inc. is a regenerative medicine company focused on developing and commercializing surgical solutions for peripheral nerve repair. The company provides technologies designed to restore sensation and functionality to individuals with damaged peripheral nerves. Its portfolio is centered on products that facilitate nerve regeneration and repair, such as the Avance® Nerve Graft, a processed human nerve allograft for bridging nerve gaps. Axogen's solutions are utilized by surgeons to treat patients with nerve injuries resulting from trauma or other medical conditions, aiming to improve their quality of life by restoring function and reducing pain.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - Axogen, Inc. (0000805928) (Filer) | 2026-04-29 | English | |
| 10-Q - Axogen, Inc. (0000805928) (Filer) | 2026-04-28 | English | |
| 8-K - Axogen, Inc. (0000805928) (Filer) | 2026-04-28 | English | |
| 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-03-03 | English | |
| 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-03-03 | English | |
| 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-03-03 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 38812505 | ARS - Axogen, Inc. (0000805928) (Filer) | 2026-04-29 | English | ||
| 38156020 | 10-Q - Axogen, Inc. (0000805928) (Filer) | 2026-04-28 | English | ||
| 37961677 | 8-K - Axogen, Inc. (0000805928) (Filer) | 2026-04-28 | English | ||
| 32881519 | 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-03-03 | English | ||
| 32881520 | 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-03-03 | English | ||
| 32881521 | 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-03-03 | English | ||
| 32881522 | 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-02-27 | English | ||
| 32881523 | 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-02-27 | English | ||
| 32881524 | 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-02-24 | English | ||
| 32881526 | 10-K - AXOGEN, INC. (0000805928) (Filer) | 2026-02-24 | English | ||
| 32881525 | 8-K - AXOGEN, INC. (0000805928) (Filer) | 2026-02-24 | English | ||
| 18776430 | 8-K Filing | 2026-01-23 | English | ||
| 18776423 | 424B5 Filing | 2026-01-23 | English | ||
| 18776405 | 424B5 Filing | 2026-01-21 | English | ||
| 18776372 | S-3ASR Filing | 2026-01-21 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Alvotech Holdings S.A
A biotechnology company developing and manufacturing biosim…
|
ALVO | LU | Manufacturing |
|
ALX ONCOLOGY HOLDINGS INC
Clinical-stage immuno-oncology company developing therapies…
|
ALXO | US | Manufacturing |
|
Alzamend Neuro, Inc.
Develops treatments for neurodegenerative diseases and psyc…
|
ALZN | US | Manufacturing |
|
Alzinova AB
Clinical-stage biopharma developing immunotherapies for Alz…
|
ALZ | SE | Manufacturing |
|
Amanta Healthcare Limited
Manufactures sterile liquid formulations using advanced Blo…
|
AMANTA | IN | Manufacturing |
|
AMARIN CORP PLC\UK
Develops and commercializes therapeutics to improve cardiov…
|
AMRN | US | Manufacturing |
|
Ambalal Sarabhai Enterprise Ltd.
Manufactures pharmaceuticals, APIs, fine chemicals, and dia…
|
AMBALALSA | IN | Manufacturing |
|
Ambrilia Biopharma Inc.
Biopharmaceutical company focused on novel treatments for o…
|
AMB | CA | Manufacturing |
|
AMGEN INC
A biotechnology company developing human therapeutics for s…
|
AMGN | US | Manufacturing |
|
Amicogen, Inc.
Industrial biotechnology company specializing in specialty …
|
092040 | KR | Manufacturing |
Axogen, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32414/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32414 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32414 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32414 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32414}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Axogen, Inc. (id: 32414)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.